BioAge Labs, Inc

10-Year Study

BIOA.US · Healthcare · US · Common Stock

Executive Summary: BioAge Labs, Inc has compounded at -12.0% annually over the last 10 years, with a maximum drawdown of 84.1% and an annualized volatility of 732.5%.

1Y CAGR
+389.3%
3Y CAGR
-12.0%
5Y CAGR
-12.0%
10Y CAGR
-12.0%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
84.1%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
0.48
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
0.58
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
90.9%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · +128.5%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2026 · 28.4%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
100%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
202643.517.3-21.5-2.9————————28.4%
2025-20.70.9-18.811.7-5.74.36.512.019.328.725.439.4128.5%
2024—————————13.5-20.3-69.2-72.2%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 732.5%. The dominant macroeconomic risk driver is VNQ.US, accounting for 27.8% of variance. Idiosyncratic stock-specific factors contribute 0.7%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2024-09-0110000
2024-10-0111346.153846153846
2024-11-019038.461538461539
2024-12-012783.653846153846
2025-01-012206.730769230769
2025-02-012225.961538461538
2025-03-011807.6923076923076
2025-04-012019.2307692307693
2025-05-011903.8461538461538
2025-06-011985.5769230769229
2025-07-012115.3846153846152
2025-08-012370.1923076923076
2025-09-012826.9230769230767
2025-10-013639.4230769230767
2025-11-014562.5
2025-12-016360.576923076923
2026-01-019129.807692307691
2026-02-0110706.730769230768
2026-03-018408.653846153846
2026-04-018168.26923076923
Annual Return Matrix
YearAnnual Return
20251.2849740932642488
20260.28420256991685555
Total Factor Risk
7.3252195650086
VTI.US Exposure
0.024207797884906786
VEA.US Exposure
0.06871642044910965
VWO.US Exposure
0.01934629699967618
QQQ.US Exposure
0.008992370618824052
VTV.US Exposure
-0.022076929219678503
IJR.US Exposure
-0.018671431792959093
QUAL.US Exposure
0.24654058136387902
SHV.US Exposure
0.02413380746022624
TLT.US Exposure
0.06896908207893729
LQD.US Exposure
0.12246477907014769
HYG.US Exposure
0.08830846876444298
GLD.US Exposure
0.015248147848181263
USO.US Exposure
0.005699056795497139
VNQ.US Exposure
0.27803823226172086
BTC-USD.CC Exposure
0.01134089232427809
CPER.US Exposure
-0.0031555260012902
VIX.INDX Exposure
0.0009416313753077347
UUP.US Exposure
0.0083715151570396
TIP.US Exposure
0.045756137399344324
Idiosyncratic Exposure
0.006828669162408972
Value Score
50
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
732.5%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$776.6M
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-11.7%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+52.3%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
25.9% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
1.00
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is BioAge Labs, Inc a high-risk investment?

BioAge Labs, Inc (BIOA.US) has an annualized volatility of 732.5% and experienced a maximum drawdown of 84.1% over the last 10 years. Its primary macro risk driver is VNQ.US.

What is the 10-year return of BIOA.US?

Over the past 10 years, BIOA.US has generated a Compound Annual Growth Rate (CAGR) of -12.0%. It has had a positive return in 100% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on BioAge Labs, Inc

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest